HCV genotype reagent
Ended Purchase Order Awarded Last action
- Contract number
- VA24717P0885
- Awardee
-
Genmark Diagnostics, Inc. UEI LCHLHA4TDUL3
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $448,506
Award facts
- Opportunity
-
- VA24717Q0112 Solicitation number
- NOTICE OF INTENT TO SOLE SOURCE HCV Genotype Reagents GenMark Diagnostics Award Notice · Posted Jan 9, 2017
- Contract value 21% obligated
-
- $448,505.70 Current, with exercised options
- $2,126,578.98 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $32,818 | |
| Other Administrative Action | -$131,270 | |
| Exercise an Option | $54,696 | |
| Change Order | -$142,210 | |
| Other Administrative Action | -$185,966 | |
| Exercise an Option | $164,088 | |
| Exercise an Option | $328,175 | |
| Other Administrative Action | $0 | |
| Original award | $328,176 |
About this award
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $2,126,578.98 contract is for the provision of HCV (hepatitis C virus) genotype reagents to support testing and screening programs for veteran populations.
The contract has no set-aside designation and is part of a larger $1.15 million blanket purchase agreement (BPA) and a $1.1 million BPA that enable the VA to rapidly acquire Genmark's ePlex analyzers, SARS-CoV-2 test kits, and other proprietary diagnostic systems and reagents. Genmark also maintains a five-year indefinite delivery vehicle (IDV) with the VA for hepatitis C virus genotyping test kits. These contract vehicles allow the VA to efficiently procure Genmark's molecular diagnostic technologies and testing supplies to assist in serving veterans through next-generation sequencing services and COVID-19 detection efforts.
Quick answers
Who was awarded contract VA24717P0885?
VA24717P0885 was awarded to Genmark Diagnostics, Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on February 6, 2017.
How much is contract VA24717P0885 worth?
The government has obligated $448,506 on VA24717P0885. Its potential value, with all options, is $2,126,579.
Was contract VA24717P0885 competed?
The extent of competition for VA24717P0885 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award